RxCap
PrivateLast Round
Series B
Apr 25, 2024
Total Funding Raised
$19.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RxCap is a healthtech company that provides a platform of connected remote monitoring solutions, including smart devices and software, to improve medication adherence and patient engagement for healthcare providers, payers, and pharmaceutical manufacturers.
Sector
Healthcare & Life Sciences
Verticals
Health IoT, Medical Devices, Patient Engagement, EHR & EMR, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxCap Comparables
Compare RxCap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AdhereTech | 83% | |
| Vaica Medical | 82% | |
| InHandPlus | 79% | |
RxCap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 25, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 139% MoM, reaching 1.1K.
- Apr 17, 2026
Monthly visitors increased 38% MoM.
RxCap Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RxCap's valuation, stock price, and market status.